rs5750285

A SNP in the LOC105373021 gene on chromosome 22. Its most notable genotype is C;C: Better response to lithium treatment

Gene
LOC105373021
Location
Chr 2236,708,203 (GRCh38)
Highest magnitude
0.0Typical
Tested on
23andMe
Minor allele frequency
49%

Genotypes

As shown in 23andMe and AncestryDNA files.

  1. C;CMost notableGoodBetter response to lithium treatmentTypical · 0.022% of people
  2. C;GGoodBetter response to lithium treatmentTypical · 0.047% of people

On SNPedia: (C;C), (C;G). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.

Frequency

Share of each genotype in 4 HapMap populations.

  • AverageC;C 22% C;G 47%
  • European ancestry (Utah)C;C 35% C;G 52%
  • Han Chinese (Beijing)C;C 31% C;G 42%
  • Japanese (Tokyo)C;C 16% C;G 46%
  • Yoruba (Nigeria)C;C 6% C;G 46%

Notes

From SNPedia

Notes

PMID 18408563 Stargazin involvement with bipolar disorder and response to lithium treatment.

Source and license

Adapted from rs5750285 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.

SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.